Nipah was first identified about 25 years ago in Malaysia and has led to outbreaks in Bangladesh, India and Singapore. The first participants in the Oxford trial received doses of the vaccine over the last week. The shot is based on the same technology as the one used in AstraZeneca and Serum Institute of India's COVID-19 shots.
The first participants in the Oxford trial received doses of the vaccine over the last week. The shot is based on the same technology as the one used in AstraZeneca (AZN.L) and Serum Institute of India's Covid-19 shots.